推薦者からの声(Prf.Markus Montag)

卵巣凍結先進国のドイツから学ぶ


卵巣凍結の先進国はドイツ・デンマークがあげられますが、

とりわけドイツではFerti Protektという凍結保存センターを中心としたネットワークが有効に機能しており、

急速に卵巣凍結における妊孕性温存が成長しています。

私たちは2016年4月にMarkus Montagをお招きして技術研修を受け、最先端の卵巣凍結技術を身に着けました。

Special Advisor:Markus Montag, Ph.D., Prof. より


Montag

Fertility preservation for women is becoming increasingly important in nowadays

society. Ovarian tissue freezing and later retransplantation has been shown to be a

successful option for fertility preservation. Meanwhile 80 healthy babies were born

worldwide using this new therapy. The concept of ovarian tissue banking in a

specialized cryobank offering the highest quality standards is considered as the best

way forward. The ovarian tissue bank opened by Dr. Kyono in Tokyo will be the first of

it´s kind in Japan. We are proud to be part of the initiative of Dr. Kyono to offer a central

ovarian tissue freezing service to Japanese women and we wish Dr. Kyono and his team

all the best in serving the Japanese society.

経歴


Markus Montag, Ph.D., Prof. (マルクス モンターク) CEO,

ilabcomm GmbH Sankt Augustin, Germany

http://www.ilabcomm.com/

Dr. Montag started his carreer at the German Cancer Research Centre in developmental biology.

He continued as post-doc in the team of Prof SC Ng, the father of the first SUZI baby at the National University Hospital Singapore.

In 1993 he started as laboratory director in IVF, first in a private IVF unit, then at the University of Bonn from 1995 to 2011 and finally

at the University of Heidelberg until 2013.

Since 2013 he serves as CEO of his consultancy company called ilabcomm.

He has published more than 200 peer reviewed articles, 20 book chapters and started editing his own books.

He is worldwide involved in counselling IVF centres, lecturing and educating young people.
Among his major achievements are the introduction of laser technology in the IVF laboratory,

the establishment of the ESHRE trial on polar body biopsy and array CGH for PGS and the foundation of

the German network for fertility protection for women (FertiPROTEKT).

His major topics of interest are the identification of the potential of embryos, time-lapse technology and ovarian tissue banking.

PAGE TOP